3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Prostatic Neoplasms
1
Premature Birth
1
Patient Compliance
1
Pain
1
Hirschsprung Disease
1
Heart Defects, Congenital
1
Head and Neck Neoplasms
1
Fatigue
1
Depression
1
Congenital Abnormalities
1
Climacteric Syndrome
1
Child Nutrition Disorders
1
Burnout, Psychological
1
Burnout, Professional
1
Anxiety Disorders
1
Acquired Immunodeficiency Syndrome
1
Interventions
Cytarabine
85
fludarabine phosphate
84
Peripheral Blood Stem Cell Transplantation
75
Cyclophosphamide
69
Busulfan
62
Mycophenolic Acid
50
Cyclosporine
48
Tacrolimus
47
Etoposide
43
Whole-Body Irradiation
41
Antilymphocyte Serum
40
Methotrexate
39
Filgrastim
39
Radiotherapy
29
Melphalan
24
Mitoxantrone
23
Daunorubicin
23
Idarubicin
21
Cord Blood Stem Cell Transplantation
18
Methylprednisolone
17
Flow Cytometry
17
sargramostim
15
Granulocyte Colony-Stimulating Factor
15
Clofarabine
15
Transplantation
14
Decitabine
14
aldesleukin
12
Gemtuzumab
12
Thiotepa
11
Bortezomib
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Congenital Abnormalities
×
Self Care
×
Clear all
NCT04150120
2026-04-06
eChildHealth
Lund University
Phase NA
Completed
720 enrolled